It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Looking for ways to make money legally in a hurry? Check out these effective tips to start earning cash quickly.
13,263 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
As the market wrestles with SaaS cycles and AI disruption fears, monday.com stock has seen its share of monday blues....
Europe confronts a rocket shortage leaves europe that threatens space infrastructure, defense planning, and private i...
A year retiree with only $400K is turning to a two-ETF income strategy to secure roughly $2,500 per month, blending e...
A record quarterly wave of AI data-center disruption worth about $130 billion has sparked a fresh warning from Mark C...
A surge in Wrapped Bitcoin (WBTC) exchange withdrawals reached a six-week peak, prompting traders to debate whether w...
XYLD has delivered steady income, yet its upside is capped. This analysis details the hidden costs and current perfor...
Bitcoin faces a steep uphill climb after last year’s peak left early buyers in the red. Analysts say a near 90% rally...
A baby boomer dad who spent years cleaning overnight helped his five children attend a private college tuition-free, ...
As crude prices rise, Occidental Petroleum trims its 2026 capital spending. This deep dive explains what the move mea...